Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 12 years
- Director since
- 2023
12 years of board service in total across 4 boards, counting each seat separately. Longest: Neurocrine Biosciences Inc., 3 years.
Neurocrine Biosciences Inc.
Director
Arvinas Inc.
Director
Globus Medical Inc.
Director
CVS Health Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2025 | Arvinas Inc. | Grant or award | +16,025 | — | — |
| May 22, 2025 | Neurocrine Biosciences Inc. | Option exercise | +1,435 | — | — |
| Nov 21, 2024 | CVS Health Corporation | Grant or award | +2,200 | $57.10 | $125,620 |
| Jul 11, 2024 | Globus Medical Inc. | Open-market sale | −1,000 | $70.00 | $70,000 |
| May 29, 2024 | Arvinas Inc. | Grant or award | +5,899 | — | — |
| May 17, 2024 | Neurocrine Biosciences Inc. | Option exercise | +2,100 | — | — |
| May 17, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −1,106 | $141.82 | $156,853 |
| Mar 15, 2024 | Globus Medical Inc. | Open-market sale | −10,590 | $51.99 | $550,574 |
| Feb 27, 2024 | Neurocrine Biosciences Inc. | Option exercise | +8,000 | $84.95 | $679,600 |
| Feb 27, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −8,000 | $135.67 | $1,085,360 |
| Sep 1, 2023 | Globus Medical Inc. | Grant or award | +2,321 | — | — |
| Sep 1, 2023 | Globus Medical Inc. | Grant or award | +25,688 | — | — |
| Jun 15, 2023 | Arvinas Inc. | Grant or award | +4,121 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.